A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

Pascal Vranckx, Freek W.A. Verheugt, Moniek P. de Maat, Victor Ulmans, Evelyn Regar, Peter Smits, Jurrien M. ten Berg, Wietze Lindeboom, Russel L. Jones, Jeffrey Friedman, Paul Reilly, Frank W.G. Leebeek
  • EuroIntervention, January 2013, Europa Digital & Publishing
  • DOI: 10.4244/eijv8i9a162
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr E Regar